KALA BIO, Inc.
KALA
Classement en actions
#30856
Kala Bio, Inc. functions as a biopharmaceutical company dedicated to the... Kala Bio, Inc. functions as a biopharmaceutical company dedicated to the creation and commercialization of new therapeutic solutions. The core of their strategy involves utilizing proprietary nanoparticle technology, specifically mucus penetrating particles (MPPs). Initially, their focus for these treatments is directed towards ophthalmic diseases. The company was established in 2009 by co-founders Justin Hanes, Robert S. Langer, and Colin R. Gardner, and its headquarters are located in Arlington, Massachusetts.
Prix de l'action
$0.75
Dernière synchronisation: 2026-07-31
Capitalisation boursière
$14.50M
Changement (1 jour)
2.78%
Changement (1 an)
-98.84%
Pays
US
Échange KALA BIO, Inc. (KALA)
Catégorie
Healthcare
Capitalisation boursière de KALA BIO, Inc.(KALA)
Capitalisation boursière: $14.50M
En October 2026, KALA BIO, Inc. a une capitalisation boursière de $14.50M. Cela fait de KALA BIO, Inc. la 30856th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de KALA BIO, Inc. du 2018 au 2026
KALA par rapport au top 5 des plus populaires stocks
| Prix pour KALA | L’actif B | La capitalisation boursière de B | Résultats | |
|---|---|---|---|---|
$37,421,230
$27.28K
|
$5.255T | +19,259,511,115.41% | ||
|
$35,553,710
$27.28K
|
$4.993T | +18,298,358,001.13% | ||
|
$29,701,719
$27.28K
|
$4.171T | +15,286,525,565.64% | ||
|
$28,210,025
$27.28K
|
$3.961T | +14,518,798,252.57% | ||
|
$20,200,082
$27.28K
|
$2.837T | +10,396,336,335.06% |
